Dinopol, Shaniah Kate .

HRN: 26-10-35  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/21/2024
10/28/2024
IV
400
Q6h
BFS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: